Effect of the tyrosine kinase inhibitors on the growth in children with Philadelphia chromosome–positive acute lymphoblastic leukemia: a case–control study

BACKGROUND: First-generation ABL-targeted tyrosine kinase inhibitor (TKI) imatinib is known to retard growth in children but it is not known if the second-generation ABL-targeted TKI dasatinib has the same effect. We aimed to determine the impact of the first- or second-generation TKI on the growth...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Jiaoyang, Liu, Hu, Chen, Yumei, Yu, Jie, Gao, Ju, Jiang, Hua, Zhai, Xiaowen, Ju, Xiuli, Wu, Xuedong, Wang, Ningling, Tian, Xin, Liang, Changda, Fang, Yongjun, Zhou, Fen, Li, Hong, Sun, Lirong, Yang, Liangchun, Guo, Jing, Liu, Aiguo, Li, Chi-kong, Zhu, Yiping, Tang, Jingyan, Yang, Jun J., Shen, Shuhong, Cheng, Cheng, Pui, Ching-Hon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544282/
https://www.ncbi.nlm.nih.gov/pubmed/37790080
http://dx.doi.org/10.1016/j.lanwpc.2023.100818

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544282/
https://www.ncbi.nlm.nih.gov/pubmed/37790080
http://dx.doi.org/10.1016/j.lanwpc.2023.100818

Ejemplares similares